Literature DB >> 10099106

Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya.

J Overbaugh1, J Kreiss, M Poss, P Lewis, S Mostad, G John, R Nduati, D Mbori-Ngacha, H Martin, B Richardson, S Jackson, J Neilson, E M Long, D Panteleeff, M Welch, J Rakwar, D Jackson, B Chohan, L Lavreys, K Mandaliya, J Ndinya-Achola, J Bwayo.   

Abstract

If human immunodeficiency virus type 1 (HIV-1) vaccines are to be highly effective, it is essential to understand the virologic factors that contribute to HIV-1 transmission. It is likely that transmission is determined, in part, by the genotype or phenotype (or both) of infectious virus present in the index case, which in turn will influence the quantity of virus that may be exchanged during sexual contact. Transmission may also depend on the fitness of the virus for replication in the exposed individual, which may be influenced by whether a virus encounters a target cell that is susceptible to infection by that specific variant. Of interest, our data suggest that the complexity of the virus that is transmitted may be different in female and male sexual exposures.

Entities:  

Mesh:

Year:  1999        PMID: 10099106     DOI: 10.1086/314792

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy.

Authors:  Ruth W Gitau; Susan M Graham; Linnet N Masese; Julie Overbaugh; Vrasha Chohan; Norbert Peshu; Barbra A Richardson; Walter Jaoko; Jeckoniah O Ndinya-Achola; R Scott McClelland
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

2.  Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya.

Authors:  J R Neilson; G C John; J K Carr; P Lewis; J K Kreiss; S Jackson; R W Nduati; D Mbori-Ngacha; D D Panteleeff; S Bodrug; C Giachetti; M A Bott; B A Richardson; J Bwayo; J Ndinya-Achola; J Overbaugh
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers.

Authors:  Laurie-Anne Batraville; Jonathan Richard; Maxime Veillette; Annie-Claude Labbé; Michel Alary; Fernand Guédou; Daniel E Kaufmann; Johanne Poudrier; Andrés Finzi; Michel Roger
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11       Impact factor: 2.205

4.  The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

Authors:  Darpun D Sachdev; Bouchra Zerhouni-Layachi; Mila Ortigoza; Albert T Profy; Michael Tuen; Catarina E Hioe; Mary E Klotman
Journal:  J Acquir Immune Defic Syndr       Date:  2009-06-01       Impact factor: 3.731

5.  An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort.

Authors:  Harold O Peters; Mark G Mendoza; Rupert E Capina; Ma Luo; Xiaojuan Mao; Michael Gubbins; Nico J D Nagelkerke; Ian Macarthur; Brent B Sheardown; Joshua Kimani; Charles Wachihi; Subo Thavaneswaran; Francis A Plummer
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

6.  Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages.

Authors:  Vasudha Sundaravaradan; Suman R Das; Rajesh Ramakrishnan; Shobha Sehgal; Sarla Gopalan; Nafees Ahmad; Shahid Jameel
Journal:  Virol J       Date:  2007-11-24       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.